Logo-npj

Meta Analysis

1. The association between the utilization of SGLT2 inhibitors and diabetic retinopathy; a systematic review and meta-analysis of cohort studies
Shahriar Barkhordari ORCID, Shahrzad Ghaffariyan ORCID, Farzin Banei ORCID, Mohammad Shirvani ORCID, Farangis yazdanjou ORCID, Sara Ghaseminejad Kermani ORCID, Mohammad Akbari ORCID, Alireza Baghaei ORCID, Mobin Mohammadtabar* ORCID
J Nephropharmacol. 2024;13(2): e12688. doi: 10.34172/npj.2024.12688
Scopus ID: 85197804266    
Article
PDF
XML
Cited By:
3
2
Letter to Editor

2. Antihypertensive effects of SGLT2 inhibitors; a letter to the editor on new concepts
Rahimeh Eskandarian ORCID, Mohammad Memarian ORCID, Samira Mehrabi Pari* ORCID
J Nephropharmacol. 2024;13(2): e12700. doi: 10.34172/npj.2024.12700
Scopus ID: 85197775476    
Article
PDF
XML
Cited By:
0
0
Review

3. Remission revolution; redefining CKD management from slowdown to reversal
Sepideh Hajian ORCID, Azadeh Zahedi Far* ORCID
J Nephropharmacol. 2026;15(2): e12855. doi: 10.34172/npj.2026.12855
Article
PDF
XML
Cited By:
Review

4. Reviving the microcirculation; the protective role of SGLT2 inhibitors in counteracting capillary rarefaction
Paniz Pourpashang* ORCID
J Nephropharmacol. 2026;15(2): e12876. doi: 10.34172/npj.12876
Article
PDF
XML
Cited By: